Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A(2) adenosine receptors regulate CFTR through PKA and PLA(2).

B R Cobb1, F Ruiz, C M King

  • 1Department of Human Genetics, University of Alabama at Birmingham, 35233, USA.

American Journal of Physiology. Lung Cellular and Molecular Physiology
|December 14, 2001
PubMed
Summary

Adenosine (Ado) activates cystic fibrosis transmembrane conductance regulator (CFTR) via A(2B) receptors, involving phospholipase A(2) (PLA(2)) and protein kinase A. This pathway enhances both wild-type and mutant CFTR activity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Distinct post-insemination dynamics between fresh and frozen-derived gametes using testicular sperm.

Journal of assisted reproduction and genetics·2025
Same author

Gut-derived metabolites drive Th17 cell pathogenicity in multiple sclerosis.

Cell reports·2025
Same author

Antibacterial effect, antiadherence, and antiacidogenicity properties of a dental varnish containing silver nanoparticles: an in vitro study.

European archives of paediatric dentistry : official journal of the European Academy of Paediatric Dentistry·2025
Same author

Online physical exercise intervention in older adults during lockdown: Can we improve the recipe?

Aging clinical and experimental research·2023
Same author

Waterborne Antifouling Paints Containing Nanometric Copper and Silver against Marine <i>Bacillus</i> Species.

Bioinorganic chemistry and applications·2022
Same author

Assessing Progress Towards SDGs Implementation Using Multiple Reference Point Based Multicriteria Methods: The Case Study of the European Countries.

Social indicators research·2022

Area of Science:

  • Cell Biology
  • Molecular Physiology
  • Respiratory Medicine

Background:

  • Adenosine (Ado) is a key signaling molecule in various physiological processes.
  • The cystic fibrosis transmembrane conductance regulator (CFTR) is a crucial ion channel implicated in cystic fibrosis.
  • Understanding CFTR regulation is vital for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the role of adenosine (Ado) in activating the cystic fibrosis transmembrane conductance regulator (CFTR).
  • To elucidate the specific signaling pathways involved in Ado-mediated CFTR activation, including receptors and enzymes.
  • To assess the potential of this pathway to modulate both wild-type and mutant CFTR function.

Main Methods:

  • In vitro studies using various cell lines (Calu-3, IB-3-1, COS-7) and primary human airway cells.

Related Experiment Videos

  • In vivo experiments utilizing wild-type and CFTR-deficient mice.
  • Measurement of intracellular cAMP levels, halide efflux, and arachidonic acid release.
  • Pharmacological inhibition of specific receptors (A(2B)) and enzymes (PLA(2), cPLA(2)).
  • Expression studies involving wild-type, DeltaF508, and G551D mutant CFTR.

    • Main Results:

    • A(2B) adenosine receptors were identified in airway cells and mediated Ado-induced cAMP elevation and protein kinase A-dependent halide efflux.
    • Adenosine stimulated arachidonic acid release, and phospholipase A(2) (PLA(2)) inhibition blocked Ado-activated halide efflux, indicating PLA(2) involvement.
    • Ado stimulated CFTR-dependent nasal chloride secretion in mice, sensitive to A(2) receptor and PLA(2) blockade.
    • Adenosine activated halide efflux in cells expressing both wild-type and mutant CFTR (DeltaF508, G551D), with the latter requiring additional factors.

    Conclusions:

    • Phospholipase A(2) (PLA(2)) and protein kinase A (PKA) are essential components of A(2B) receptor-mediated activation of CFTR.
    • This signaling pathway can enhance the activity of both wild-type and mutant forms of CFTR.
    • Targeting this adenosine-mediated pathway presents a potential therapeutic avenue for cystic fibrosis and other CFTR-related disorders.